Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.

NCT03172117 is registered in ClinicalTrials.gov with Medipost Co Ltd. as lead sponsor.

NCT NCT03172117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03172117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.
Lead sponsor
Medipost Co Ltd.
Phase
Phase 1/2
Overall status
Completed
Start date
May 19, 2017
Completion date
March 18, 2022
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease